A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood Pressure
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
After a wash-out (1 to 2 weeks), and 2 to 4 week single-blind placebo run-in period, eligible
patients will be randomized to receive lisinopril 10 mg, aliskiren 75 mg, 150 mg or 300 mg
for a period of 8 weeks